Plain-English translation of NCT06264427 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand why metabolic diseases—like type 2 diabetes and obesity—develop differently in Greenlandic Inuit communities compared to other populations. This study will collect genetic information and health data from people with these conditions to identify specific genes that affect how these diseases develop and progress. By learning more about the genetics of metabolic disease in this population, researchers hope to create personalized treatment approaches tailored to people's unique genetic makeup.
Greenlandic Inuit people have different genetic backgrounds and living environments than Western populations, which may affect how metabolic diseases develop. This research aims to discover genetic variations that influence these diseases in Arctic communities, so doctors can offer better, more personalized care based on each person's genes.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have your DNA sequenced and undergo health evaluations to check for diabetes complications and sleep apnea. The study will also provide treatment for any of these conditions if you qualify and need it. The visits will take place at a research center in Greenland, and researchers will work with you to ensure the care is appropriate for your needs.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Greenland
Sponsor
Steno Diabetes Center Greenland
Collaborators
Zealand University Hospital, University of Copenhagen
Enrollment target
~1,000 participants
Started
July 2022
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mads Jensen, MD.
Steno Diabetes Center Greenland
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.